CALR and essential thrombocythemia: Using ASO-PCR and conventional Sanger sequencing method, we found that 84.8% of 395 ET patients carried JAK2V617F, CALR, or MPL mutations, underscoring the importance of combined genetic tests for diagnosis of ET patients.